Evolution of the Average Target: DaShenLin Pharmaceutical Group Co., Ltd.

Evolution of the Average Target - DaShenLin Pharmaceutical Group Co., Ltd.

Evolution of the Target Price: DaShenLin Pharmaceutical Group Co., Ltd.

Evolution of the Target Price - DaShenLin Pharmaceutical Group Co., Ltd.

Changes in Analyst Recommendations: DaShenLin Pharmaceutical Group Co., Ltd.

295a784fbf7.CqLEpQ5QcjRaFYpfk2IhOsUWGoBUXBO6zMCfILP9Qc4.Z8-F80MjBkUQT-Ar5gVEa5Z0TrAmDnDMh4bYcP66HqZd1YDhRggLYCJh5Q~e7f6a9a80a236af90be668f028efa373

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
Average
Weighted average by Cap.


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
18.61CNY
Average target price
23.75CNY
Spread / Average Target
+27.62%
High Price Target
26.40CNY
Spread / Highest target
+41.86%
Low Price Target
15.00CNY
Spread / Lowest Target
-19.40%

Analyst Consensus Detail

Analyst consensus - DaShenLin Pharmaceutical Group Co., Ltd.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - DaShenLin Pharmaceutical Group Co., Ltd.
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - DaShenLin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 603233 Stock
  4. Consensus DaShenLin Pharmaceutical Group Co., Ltd.